APA (7th ed.) Citation

NA, E., ME, E., AH, E., & SE, A. (2021). Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signaling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuates progression of oxazolone-induced colitis. Fundamental & clinical pharmacology, 35(1), 143. https://doi.org/10.1111/fcp.12563

Chicago Style (17th ed.) Citation

NA, El-Mahdy, El-Sayad ME, El-Kadem AH, and Abu-Risha SE. "Targeting IL-10, ZO-1 Gene Expression and IL-6/STAT-3 Trans-signaling by a Combination of Atorvastatin and Mesalazine to Enhance Anti-inflammatory Effects and Attenuates Progression of Oxazolone-induced Colitis." Fundamental & Clinical Pharmacology 35, no. 1 (2021): 143. https://doi.org/10.1111/fcp.12563.

MLA (9th ed.) Citation

NA, El-Mahdy, et al. "Targeting IL-10, ZO-1 Gene Expression and IL-6/STAT-3 Trans-signaling by a Combination of Atorvastatin and Mesalazine to Enhance Anti-inflammatory Effects and Attenuates Progression of Oxazolone-induced Colitis." Fundamental & Clinical Pharmacology, vol. 35, no. 1, 2021, p. 143, https://doi.org/10.1111/fcp.12563.